Literature DB >> 21228996

Treatment of Asymptomatic Hyperuricemia: When do you have a good reason to provide therapy?

R M Richardson.   

Abstract

Treatment of asymptomatic hyperuricemia to prevent gout, renal failure, or kidney stones is not justified. Similarly, the risks of developing either renal failure or kidney stones as a consequence of asymptomatic hyperuricemia are extremely low and do not justify intervention. Only in tumor lysis syndromes is therapy to prevent acute renal failure logical. Serum urate measurement should be requested in only very limited clinical circumstances.

Entities:  

Year:  1991        PMID: 21228996      PMCID: PMC2145258     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  6 in total

1.  Treating hypercholesterolemia. How should practicing physicians interpret the published data for patients?

Authors:  A S Brett
Journal:  N Engl J Med       Date:  1989-09-07       Impact factor: 91.245

2.  Requiem for gouty nephropathy.

Authors:  L H Beck
Journal:  Kidney Int       Date:  1986-08       Impact factor: 10.612

3.  Renal outcomes of gout and hyperuricemia.

Authors:  W J Fessel
Journal:  Am J Med       Date:  1979-07       Impact factor: 4.965

4.  Asymptomatic hyperuricemia. The case for benign neglect.

Authors:  B H Littman
Journal:  Postgrad Med       Date:  1985-05-01       Impact factor: 3.840

5.  Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma.

Authors:  L F Cohen; J E Balow; I T Magrath; D G Poplack; J L Ziegler
Journal:  Am J Med       Date:  1980-04       Impact factor: 4.965

6.  Impaired renal function gout: its association with hypertensive vascular disease and intrinsic renal disease.

Authors:  T F Yü; L Berger
Journal:  Am J Med       Date:  1982-01       Impact factor: 4.965

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.